Glucagon-like peptide-1 agonists and general anesthesia: Perioperative considerations and the utility of gastric ultrasound
Osteomalacia had the greatest relative risk increase, with a five-year incidence of 0.2 percent among GLP-1 RA users compared with 0.1 percent in the control group (risk ratio, 2.55)
They are prepared by licensed compounding pharmacies under physician prescription and have not been evaluated through clinical trials for safety, efficacy, or therapeutic equivalence to any FDA-approved medications
Recognition of gastric emptying effects with GLP-1 medications has prompted guidance from regulatory agencies and professional medical societies to inform clinical practice
This guide does not do that
A research study discovered that within a sample of 100 male and female volunteers who were not diagnosed with diabetes and had no prior history of cardiovascular disease, individuals who met the ATP-III criteria for MetS exhibited a higher degree of endothelial dysfunction than those who did not
:max_bytes(150000):strip_icc()/VWH-GettyImages-2285316923-4aa76c6d6ae84d0ab0334146988a860f.jpg)
